期刊文献+

以双歧杆菌为载体实现量子点在体靶向肿瘤的可行性研究 被引量:2

Feasibility of in Vivo Imaging using Bifidobacterium bifidum as a Carrier for Delivering Quantum Dots into Tumors
下载PDF
导出
摘要 应用双歧双歧杆菌作为量子点输送载体,为小动物在体生物肿瘤成像提供依据.采用电穿孔方法,将二棕榈酰磷脂酰胆碱(DPPC)包被的硫硒镉水溶性量子点转入细菌内,得到"量子点-细菌"复合探针,在"量子点-细菌"表面通过1-(3-二甲氨基丙基)-3-乙基碳二亚胺(EDC)活化法进一步偶联叶酸分子,制得"量子点-细菌-叶酸"复合纳米生物探针.将纳米生物探针经尾静脉注入Lewis肺癌小鼠体内,采用冰冻组织切片,考察探针在小鼠体内脏器及肿瘤的分布情况.结果表明,在肿瘤部位检测到较强的量子点光致发光信号,而在肺、肝、脾等脏器中只检测到微弱的量子点发光信号."量子点-细菌-叶酸"复合纳米生物探针小动物在体肿瘤靶向成像是可行的. To evaluate the feasibility of in vivo tumor-specific imaging in small animals,Bifidobacterium bifidum was loaded with quantum dots(QDs) and used as a carrier for detecting tumor transplants.First,CdSeS QDs coated with water soluble dipalmitoyl phosphatidylcholine(DPPC) were introduced into B.Bifidum via electroporation.Then,folic acid was used as the second target substance to enhance the affinity of B.Bifidum to tumors through(1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide,EDC) activation method.Last,the obtained QD-B.Bifidum-FA nanobioprobes were intravenously injected into tumor-bearing mice.The frozen tissue sections were used for evaluating the distribution the nanobioprobes in vivo.Stronger characteristic QDs photoluminescence signals were observed in tumors than in other tissues,such as lung,liver and spleen.These results indicated that QD-B.Bifidum-FA nanobioprobes could be used for labeling tumors in small animals in vivo.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2012年第9期864-869,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金项目(No.20973008 No.30470523)~~
关键词 量子点 双歧双歧杆菌 荷瘤小鼠 电穿孔 叶酸 quantum dots Bifidobacterium bifidum tumor-bearing mice electroporation folic acid
  • 相关文献

参考文献15

  • 1Michalet X, Pinaud F F, Bentolila L A, et al. Quantum dots for live ceils, in vivo imaging, and diagnostics [ J]. Science, 2005, 307(5709) :538-544.
  • 2Akerman M E, Chart W C, Laakkonen P, et al. Nanocrystal targeting in vivo [ J]. Proce Nat Acad Scie USA, 2002, 99 (20) :12617-12621.
  • 3Ballou B, Lagerholm B C, Ernst L A, et al. Noninvasive imaging of quantum dots in mice [ J ]. Bioconjug Chem, 2004, 15 (1) : 79-86.
  • 4Gao X, Cui Y, Levenson R M, et al. In vivo cartcer targeting and imaging with semiconductor quantum dots [ J ]. Nat Biotechnol, 2004, 22 (8) :969-976.
  • 5Tredan O, Galmarini C M, Patel K, et al. Drug resistance and the solid tumor microenvironment [ J]. J Natil Cancer Inst, 2007, 99(19) :1441-1454.
  • 6Jain R K, Forbes N S. Can engineered bacteria help control cancer? [J]. Proc Nati Acad Sci USA, 2001, 98(26) : 14748- 14750.
  • 7Brown J M, Giaccia A J. The unique physiology of solid tumors:opportunities (and problems) for cancer therapy [ J ]. Cancer Res, 1998, 58(7) :1408-1416.
  • 8Gunasekera U A, Pankhurst Q A, Douek M. Imaging applications of nanotechnology in cancer [ J ]. Target oncol, 2009, 4(3) :169-181.
  • 9Reddy B S, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo [ 4,5-f] quinoline, a food mutagen [ J ]. Cancer Res, 1993, 53 (17) :3914-3918.
  • 10Ryan R M, Green J, Lewis C E. Use of bacteria in anti-cancer therapies [ J ]. Bioessays, 2006, 28 ( 1 ) :84-94.

同被引文献27

  • 1何霞,陈明霞,羊建.抗环瓜氨酸肽抗体检测对类风湿性关节炎的诊断价值[J].实用医院临床杂志,2009,6(6):77-78. 被引量:9
  • 2胡华军,付涛,张明洲,洪治,陈宗伦,刘军.CdTe/ZnSe核壳量子点免疫层析试纸条检测克伦特罗的研究[J].分析化学,2010,38(12):1727-173l. 被引量:32
  • 3徐朝焰,赵素萍,吴美辉,林立人,余喜然.抗环瓜氨酸肽抗体对类风湿关节炎的诊断意义[J].中华风湿病学杂志,2005,9(11):700-701. 被引量:20
  • 4Arnett F C, Edworthy S M, Bloch D A, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[ J]. Arthritis Rheum, 1988,31 ( 3 ) : 315- 324.
  • 5Saraux A, Berthelot J M, Chales G, et al. Ability of the America College of Rheumatology 1987 criteria to predict rheumatoidarthritis in patients with early arthritis and classification of these patients two years later [ J ]. Arthritis Rheum, 2001,44 ( 11 ) : 2485-2491.
  • 6van Venrooij W J, Zendman A J, Pruijin G J. Autoantibodies to citrullinated antigens in ( early ) rheumatoid arthritis [ J ]. Autoimmun Rev,2006,6( 1 ) :37-41.
  • 7Zendman AJ, van Venrooij W J, Pruijn G J. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis [ J]. Rheumatology ( Oxford), 2006, 45( 1 ) :20-25.
  • 8Schcllekens G A, de JongBA, van den Hoogen F H, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis2specific autoantibodies[ J]. J Clin Invest, 1998,101( 1 ) :273-281.
  • 9Schellekens G A, Visser H, de Jong B A, et al. The diagnostic properties of rheumatiod arthritis antibodies recognizing a cyclic citrullinated peptide [ J ]. Arthritis Rheum, 2000,43 ( 1 ) : 155- 163.
  • 10Kahenhauser S, Pierer M, Arnold S, et al. Antibodies against cyclic citrullinated peptide are associated with the DRBI shared epitope and predict joint erosion in rheumatoid arthritis[ J ]. Rheumatology( Oxford), 2007,46 ( 1 ) :100-104.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部